GlycoMimetics, Inc. (GLYC)
NASDAQ: GLYC · Real-Time Price · USD
0.318
-0.012 (-3.73%)
Nov 21, 2024, 2:39 PM EST - Market open
GlycoMimetics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue | 0.01 | 0.01 | 0.08 | 1.16 | 10.16 | - | |
Revenue Growth (YoY) | - | -86.67% | -93.53% | -88.59% | - | - | |
Gross Profit | 0.01 | 0.01 | 0.08 | 1.16 | 10.16 | - | |
Selling, General & Admin | 17.48 | 19.21 | 19.09 | 17.12 | 16.74 | 14.36 | |
Research & Development | 19.31 | 20.07 | 28.39 | 47.49 | 44.93 | 47.03 | |
Operating Expenses | 36.79 | 39.29 | 47.48 | 64.61 | 61.67 | 61.39 | |
Operating Income | -36.78 | -39.28 | -47.4 | -63.45 | -51.51 | -61.39 | |
Interest & Investment Income | 1.34 | 2.38 | 0.71 | 0.02 | 0.48 | 3.5 | |
Pretax Income | -39.74 | -36.9 | -46.69 | -63.43 | -51.03 | -57.89 | |
Net Income | -39.74 | -36.9 | -46.69 | -63.43 | -51.03 | -57.89 | |
Net Income to Common | -39.74 | -36.9 | -46.69 | -63.43 | -51.03 | -57.89 | |
Shares Outstanding (Basic) | 64 | 63 | 53 | 51 | 46 | 43 | |
Shares Outstanding (Diluted) | 64 | 63 | 53 | 51 | 46 | 43 | |
Shares Change (YoY) | 6.56% | 20.58% | 2.10% | 12.54% | 5.70% | 5.38% | |
EPS (Basic) | -0.62 | -0.58 | -0.89 | -1.23 | -1.12 | -1.34 | |
EPS (Diluted) | -0.62 | -0.58 | -0.89 | -1.23 | -1.12 | -1.34 | |
Free Cash Flow | -35.02 | -34.9 | -46.54 | -57.5 | -39.31 | -52.13 | |
Free Cash Flow Per Share | -0.54 | -0.55 | -0.89 | -1.12 | -0.86 | -1.21 | |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | - | |
Operating Margin | -367847.59% | -392752.93% | -63204.43% | -5470.69% | -506.84% | - | |
Profit Margin | -397350.46% | -368994.20% | -62251.74% | -5468.98% | -502.09% | - | |
Free Cash Flow Margin | -350223.62% | -349012.97% | -62055.57% | -4958.28% | -386.80% | - | |
EBITDA | -36.73 | -39.12 | -47.2 | -63.18 | -51.24 | -61.11 | |
D&A For EBITDA | 0.06 | 0.15 | 0.21 | 0.26 | 0.27 | 0.28 | |
EBIT | -36.78 | -39.28 | -47.4 | -63.45 | -51.51 | -61.39 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.